Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Karthik KuppusamySVP, Clinical Solutions | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 06/04 | 06/08 | 8,147 sh | $200.00 | $1,629,400 | −37.6% |
J. E. DavisCEO and President | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 06/01 | 06/02 | 10,000 sh | $194.14 | $1,941,400 | −7.0% |
Prevoznik Michael E.SVP & General Counsel | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 03/05 | 03/06 | 3,878 sh | $206.21 | $799,682.38 | −9.4% |
Patrick PlewmanSVP for Diagnostic Services | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 03/05 | 03/06 | 2,855 sh | $206.21 | $588,729.55 | −15.8% |
Doherty Catherine T.EVP, Regional Businesses | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 03/05 | 03/06 | 5,558 sh | $206.21 | $1,146,115.18 | −7.6% |
Karthik KuppusamySVP, Clinical Solutions | Quest DiagnosticsDGX | Open-market sale | 03/04 | 03/06 | 2,628 sh | $204.86 | $538,372.08 | −16.4% |
Prevoznik Michael E.SVP & General Counsel | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 03/03 | 03/04 | 526 sh | $207.73 | $109,265.98 | −1.4% |
Patrick PlewmanSVP for Diagnostic Services | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 03/03 | 03/04 | 410 sh | $207.73 | $85,169.3 | −2.6% |
Doherty Catherine T.EVP, Regional Businesses | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 03/03 | 03/04 | 632 sh | $207.73 | $131,285.36 | −0.9% |
J. E. DavisCEO and President | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 03/02 | 03/04 | 10,000 sh | $212.52 | $2,125,200 | −7.9% |
Prevoznik Michael E.SVP & General Counsel | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 02/19 | 02/20 | 1,111 sh | $204.83 | $227,566.13 | −2.8% |
Patrick PlewmanSVP for Diagnostic Services | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 02/19 | 02/20 | 958 sh | $204.83 | $196,227.14 | −5.7% |
Doherty Catherine T.EVP, Regional Businesses | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 02/19 | 02/20 | 1,433 sh | $204.83 | $293,521.39 | −2.1% |
Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 02/13 | 02/17 | 26,165 sh5 trades | $206.15avg. | $5,393,828.56 | −27.8% | |
Patrick PlewmanSVP for Diagnostic Services | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 02/10 | 02/12 | 5,662 sh | $204.00 | $1,155,048 | −26.9% |
Gregg Vicky B.Director | Quest DiagnosticsDGX | Open-market sale | 25/11/25 | 25/11/28 | 1,250 sh | $191.76 | $239,700 | −6.8% |
Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 25/11/25 | 25/11/28 | 55,093 sh3 trades | $192.22avg. | $10,589,701.45 | −31.4% | |
Delaney Mark E.SVP & Chief Commercial Officer | Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 25/11/18 | 25/11/20 | 7,946 sh | $187.35 | $1,488,683.1 | −51.3% |
Gary M. PfeifferDirector | Quest DiagnosticsDGX | Open-market sale | 25/10/22 | 25/10/24 | 1,482 sh | $182.40 | $270,316.8 | −4.8% |
Quest DiagnosticsDGX | Open-market sale10b5-1 plan | 25/09/26 | 25/09/30 | 227 sh2 trades | $188.13avg. | $42,706.3 | −0.6% |